HealthHighConfirmedAccelerating
7.8
US Integrates AI Agents into Medical Care Amid Safety and VC Influence Concerns
New York Times·US·1 day ago
OpenAI's top lobbyist stated that AI capabilities are in a 'different place' and require urgent policy attention, suggesting a window for regulation still exists. The statement signals a shift in OpenAI's public posture toward proactive engagement with policymakers, likely in response to accelerating AI development and competitive pressures. The exact policy proposals remain unspecified, and the impact on regulatory timelines is uncertain.